Marcaine Glucose

Bupivacaine hydrochloride, the active ingredient in Marcaine Glucose, is a local anesthetic (amide) presented as a sterile solution for infiltration and intrathecal use. It provides regional loss of sensation for minor surgical procedures, spinal anesthesia, and peripheral nerve blocks in adult patients.

GNH USA supplies Marcaine Glucose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets.

Bupivacaine hydrochloride is a local anesthetic used to achieve regional nerve blockade.

- Local infiltration anesthesia: provides loss of sensation for minor surgical procedures. - Spinal (intrathecal) anesthesia: produces profound sensory block for surgeries requiring spinal anesthesia. - Regional nerve block: enables targeted anesthesia of specific peripheral nerves during operative or diagnostic procedures.

Bupivacaine may cause a range of adverse reactions, from mild to severe, depending on dose and administration technique.

Common Side Effects: - Transient pain or burning at the injection site. - Hypotension due to sympathetic blockade. - Bradycardia, especially with high spinal levels. - Nausea or vomiting. - Dizziness or light‑headedness. - Metallic taste.

Serious or Rare Side Effects: - Cardiac arrhythmias, including ventricular tachycardia. - Seizures from central nervous system toxicity. - Methemoglobinemia. - Allergic reactions, including anaphylaxis. - Persistent neurologic deficits. - Respiratory depression.

When using Marcaine Glucose, clinicians should observe several safety measures.

- Patient assessment: evaluate cardiovascular and hepatic status before administration. - Dose limitation: avoid exceeding the recommended maximum dose for the specific route. - Caution in hepatic impairment: adjust use as metabolism may be reduced. - Avoid intravascular injection: aspirate before injecting to prevent systemic toxicity. - Monitoring: observe patients for signs of systemic toxicity during and after the procedure. - Store at ambient temperature: keep in original container, protect from light and moisture.

Bupivacaine can interact with other medications, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase cardiotoxicity. - Beta‑blockers: can exacerbate bradycardia. - General anesthetics such as halothane: may potentiate central nervous system depression.

Moderate Interactions (Monitor Closely): - Opioids: additive central nervous system depression. - Sedatives (benzodiazepines): may increase sedation and respiratory depression.